Acquisition of DIAsource ImmunoAssays by Biovendor
Effective 5 September 2017, Biovendor – Laboratorní medicína a.s. (BioVendor) acquired 100% of the shares of DIAsource ImmunoAssays SA from the Australian stock listed company Anteo Diagnostics (ASX: ADO). Anteo Diagnostics had acquired DIAsource in January 2016. DIAsource ImmunoAssays is a Belgian company specialized for 30 years in the development, manufacturing, and sales and distribution […]
